ID

25848

Description

Safety Study of Tecadenoson to Treat Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT00713401

Lien

https://clinicaltrials.gov/show/NCT00713401

Mots-clés

  1. 21/09/2017 21/09/2017 -
Téléchargé le

21 septembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Atrial Fibrillation NCT00713401

Eligibility Atrial Fibrillation NCT00713401

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
have a diagnosis of atrial fibrillation in need of treatment for rate control
Description

Atrial Fibrillation | Treatment required for rate control

Type de données

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2,1]
C0332121
UMLS CUI [2,2]
C0489879
be able and willing to abstain from any antiarrhythmics, including atrioventricular (av) nodal blocking agents (except for esmolol per protocol), from no later than 8:00 p.m. on the day prior to dosing until completion of the last dose period assessment
Description

Abstinence Anti-Arrhythmia Agents | Abstinence Pharmaceutical Preparations AV node Blocking | Exception Esmolol

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843422
UMLS CUI [1,2]
C0003195
UMLS CUI [2,1]
C3843422
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0004247
UMLS CUI [2,4]
C0332206
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0116569
be able and willing to abstain from xanthine- or chocolate-containing foods, beverages, and medications
Description

Abstinence Food Containing Xanthine | Abstinence Food Containing Chocolate | Abstinence Beverages Containing Xanthine | Abstinence Beverages Containing Chocolate | Abstinence Pharmaceutical Preparations Containing Xanthine | Abstinence Pharmaceutical Preparations Containing Chocolate

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843422
UMLS CUI [1,2]
C0016452
UMLS CUI [1,3]
C0332256
UMLS CUI [1,4]
C0043314
UMLS CUI [2,1]
C3843422
UMLS CUI [2,2]
C0016452
UMLS CUI [2,3]
C0332256
UMLS CUI [2,4]
C0008299
UMLS CUI [3,1]
C3843422
UMLS CUI [3,2]
C0005329
UMLS CUI [3,3]
C0332256
UMLS CUI [3,4]
C0043314
UMLS CUI [4,1]
C3843422
UMLS CUI [4,2]
C0005329
UMLS CUI [4,3]
C0332256
UMLS CUI [4,4]
C0008299
UMLS CUI [5,1]
C3843422
UMLS CUI [5,2]
C0013227
UMLS CUI [5,3]
C0332256
UMLS CUI [5,4]
C0043314
UMLS CUI [6,1]
C3843422
UMLS CUI [6,2]
C0013227
UMLS CUI [6,3]
C0332256
UMLS CUI [6,4]
C0008299
females must be post-menopausal or sterilized; or if of childbearing potential, must not be breastfeeding and must have a negative pregnancy test at screening and no intention of becoming pregnant during the course of the study. males and females must be using adequate contraception during the study.
Description

Postmenopausal state | Female Sterilization | Childbearing Potential Breast Feeding Absent | Childbearing Potential Pregnancy test negative | Childbearing Potential Planned Pregnancy Absent | Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0015787
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0006147
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0427780
UMLS CUI [5,1]
C3831118
UMLS CUI [5,2]
C0032992
UMLS CUI [5,3]
C0332197
UMLS CUI [6]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
have a known accessory pathway
Description

Accessory cardiac pathway

Type de données

boolean

Alias
UMLS CUI [1]
C1963785
have active myocardial ischemia or recent acute coronary syndrome
Description

Myocardial Ischemia | Acute Coronary Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0151744
UMLS CUI [2]
C0948089
have acute or overt heart failure, bradycardia, heart block greater than first degree, or cardiogenic shock
Description

Heart failure | Bradycardia | Second degree atrioventricular block | Complete atrioventricular block | Shock, Cardiogenic

Type de données

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C0428977
UMLS CUI [3]
C0264906
UMLS CUI [4]
C0151517
UMLS CUI [5]
C0036980
have allergies or contraindications to treatment with esmolol or aminophylline, or any of their constituents
Description

Esmolol allergy | Aminophylline allergy | Hypersensitivity Esmolol Constituents | Hypersensitivity Aminophylline Constituents | Medical contraindication Esmolol | Medical contraindication Aminophylline | Medical contraindication Esmolol Constituents | Medical contraindication Aminophylline Constituents

Type de données

boolean

Alias
UMLS CUI [1]
C0570888
UMLS CUI [2]
C0571074
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0116569
UMLS CUI [3,3]
C0729650
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0002575
UMLS CUI [4,3]
C0729650
UMLS CUI [5,1]
C1301624
UMLS CUI [5,2]
C0116569
UMLS CUI [6,1]
C1301624
UMLS CUI [6,2]
C0002575
UMLS CUI [7,1]
C1301624
UMLS CUI [7,2]
C0116569
UMLS CUI [7,3]
C0729650
UMLS CUI [8,1]
C1301624
UMLS CUI [8,2]
C0002575
UMLS CUI [8,3]
C0729650
have a supine cuff systolic blood pressure < 90 mm hg
Description

Lying systolic blood pressure

Type de données

boolean

Alias
UMLS CUI [1]
C1319895
be undergoing treatment with theophylline/aminophylline preparations, trental®
Description

Theophylline | Aminophylline | Trental

Type de données

boolean

Alias
UMLS CUI [1]
C0039771
UMLS CUI [2]
C0002575
UMLS CUI [3]
C0699487
(pentoxifylline), or carbamazepine
Description

Pentoxifylline | Carbamazepine

Type de données

boolean

Alias
UMLS CUI [1]
C0030899
UMLS CUI [2]
C0006949
have asthma or other reactive airways disease currently on-treatment
Description

Therapeutic procedure Asthma | Therapeutic procedure Reactive airway disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0004096
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C3714497
have a history of an active or chronic pancreatic disease or clinically significant increased levels of serum amylase or lipase
Description

Pancreatic Disease | Pancreatic Disease chronic | Serum amylase raised | Serum lipase raised

Type de données

boolean

Alias
UMLS CUI [1]
C0030286
UMLS CUI [2,1]
C0030286
UMLS CUI [2,2]
C0205191
UMLS CUI [3]
C0476327
UMLS CUI [4]
C3670924

Similar models

Eligibility Atrial Fibrillation NCT00713401

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Atrial Fibrillation | Treatment required for rate control
Item
have a diagnosis of atrial fibrillation in need of treatment for rate control
boolean
C0004238 (UMLS CUI [1])
C0332121 (UMLS CUI [2,1])
C0489879 (UMLS CUI [2,2])
Abstinence Anti-Arrhythmia Agents | Abstinence Pharmaceutical Preparations AV node Blocking | Exception Esmolol
Item
be able and willing to abstain from any antiarrhythmics, including atrioventricular (av) nodal blocking agents (except for esmolol per protocol), from no later than 8:00 p.m. on the day prior to dosing until completion of the last dose period assessment
boolean
C3843422 (UMLS CUI [1,1])
C0003195 (UMLS CUI [1,2])
C3843422 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0004247 (UMLS CUI [2,3])
C0332206 (UMLS CUI [2,4])
C1705847 (UMLS CUI [3,1])
C0116569 (UMLS CUI [3,2])
Abstinence Food Containing Xanthine | Abstinence Food Containing Chocolate | Abstinence Beverages Containing Xanthine | Abstinence Beverages Containing Chocolate | Abstinence Pharmaceutical Preparations Containing Xanthine | Abstinence Pharmaceutical Preparations Containing Chocolate
Item
be able and willing to abstain from xanthine- or chocolate-containing foods, beverages, and medications
boolean
C3843422 (UMLS CUI [1,1])
C0016452 (UMLS CUI [1,2])
C0332256 (UMLS CUI [1,3])
C0043314 (UMLS CUI [1,4])
C3843422 (UMLS CUI [2,1])
C0016452 (UMLS CUI [2,2])
C0332256 (UMLS CUI [2,3])
C0008299 (UMLS CUI [2,4])
C3843422 (UMLS CUI [3,1])
C0005329 (UMLS CUI [3,2])
C0332256 (UMLS CUI [3,3])
C0043314 (UMLS CUI [3,4])
C3843422 (UMLS CUI [4,1])
C0005329 (UMLS CUI [4,2])
C0332256 (UMLS CUI [4,3])
C0008299 (UMLS CUI [4,4])
C3843422 (UMLS CUI [5,1])
C0013227 (UMLS CUI [5,2])
C0332256 (UMLS CUI [5,3])
C0043314 (UMLS CUI [5,4])
C3843422 (UMLS CUI [6,1])
C0013227 (UMLS CUI [6,2])
C0332256 (UMLS CUI [6,3])
C0008299 (UMLS CUI [6,4])
Postmenopausal state | Female Sterilization | Childbearing Potential Breast Feeding Absent | Childbearing Potential Pregnancy test negative | Childbearing Potential Planned Pregnancy Absent | Contraceptive methods
Item
females must be post-menopausal or sterilized; or if of childbearing potential, must not be breastfeeding and must have a negative pregnancy test at screening and no intention of becoming pregnant during the course of the study. males and females must be using adequate contraception during the study.
boolean
C0232970 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0006147 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C3831118 (UMLS CUI [4,1])
C0427780 (UMLS CUI [4,2])
C3831118 (UMLS CUI [5,1])
C0032992 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
C0700589 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
Accessory cardiac pathway
Item
have a known accessory pathway
boolean
C1963785 (UMLS CUI [1])
Myocardial Ischemia | Acute Coronary Syndrome
Item
have active myocardial ischemia or recent acute coronary syndrome
boolean
C0151744 (UMLS CUI [1])
C0948089 (UMLS CUI [2])
Heart failure | Bradycardia | Second degree atrioventricular block | Complete atrioventricular block | Shock, Cardiogenic
Item
have acute or overt heart failure, bradycardia, heart block greater than first degree, or cardiogenic shock
boolean
C0018801 (UMLS CUI [1])
C0428977 (UMLS CUI [2])
C0264906 (UMLS CUI [3])
C0151517 (UMLS CUI [4])
C0036980 (UMLS CUI [5])
Esmolol allergy | Aminophylline allergy | Hypersensitivity Esmolol Constituents | Hypersensitivity Aminophylline Constituents | Medical contraindication Esmolol | Medical contraindication Aminophylline | Medical contraindication Esmolol Constituents | Medical contraindication Aminophylline Constituents
Item
have allergies or contraindications to treatment with esmolol or aminophylline, or any of their constituents
boolean
C0570888 (UMLS CUI [1])
C0571074 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0116569 (UMLS CUI [3,2])
C0729650 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0002575 (UMLS CUI [4,2])
C0729650 (UMLS CUI [4,3])
C1301624 (UMLS CUI [5,1])
C0116569 (UMLS CUI [5,2])
C1301624 (UMLS CUI [6,1])
C0002575 (UMLS CUI [6,2])
C1301624 (UMLS CUI [7,1])
C0116569 (UMLS CUI [7,2])
C0729650 (UMLS CUI [7,3])
C1301624 (UMLS CUI [8,1])
C0002575 (UMLS CUI [8,2])
C0729650 (UMLS CUI [8,3])
Lying systolic blood pressure
Item
have a supine cuff systolic blood pressure < 90 mm hg
boolean
C1319895 (UMLS CUI [1])
Theophylline | Aminophylline | Trental
Item
be undergoing treatment with theophylline/aminophylline preparations, trental®
boolean
C0039771 (UMLS CUI [1])
C0002575 (UMLS CUI [2])
C0699487 (UMLS CUI [3])
Pentoxifylline | Carbamazepine
Item
(pentoxifylline), or carbamazepine
boolean
C0030899 (UMLS CUI [1])
C0006949 (UMLS CUI [2])
Therapeutic procedure Asthma | Therapeutic procedure Reactive airway disease
Item
have asthma or other reactive airways disease currently on-treatment
boolean
C0087111 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C3714497 (UMLS CUI [2,2])
Pancreatic Disease | Pancreatic Disease chronic | Serum amylase raised | Serum lipase raised
Item
have a history of an active or chronic pancreatic disease or clinically significant increased levels of serum amylase or lipase
boolean
C0030286 (UMLS CUI [1])
C0030286 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0476327 (UMLS CUI [3])
C3670924 (UMLS CUI [4])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial